We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and ... Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (less than 10% of sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications. Show more
NEW YORK, Dec. 13, 2024 (GLOBE NEWSWIRE) -- Nasdaq (Nasdaq: NDAQ) today announced the results of the annual reconstitution of the Nasdaq-100 Index® (Nasdaq: NDX®), which will become effective...
Illumina To Webcast Upcoming Investor Conference PR Newswire SAN DIEGO, Dec. 4, 2024 SAN DIEGO, Dec. 4, 2024 /PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN) today announced that its executives will...
Synaffix Licenses Metal-Free Click Chemistry Technology to Illumina for Next-Generation DNA Sequencing Applications PR Newswire AMSTERDAM, Dec. 4, 2024 Agreement grants access to Synaffix patent...
SALT LAKE CITY, Nov. 20, 2024 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic testing and precision medicine, announced updates to its agreement with Illumina Inc...
Illumina announces expansion of TruSight Oncology portfolio PR Newswire SAN DIEGO, Nov. 19, 2024 The latest solution to enable comprehensive genomic profiling of tumors will be presented at...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -1.169 | -0.868054266386 | 134.669 | 137.69 | 130.31 | 4532729 | 135.68797161 | CS |
4 | -10.55 | -7.32384588684 | 144.05 | 151.7496 | 130.31 | 2259378 | 139.95689305 | CS |
12 | -4.71 | -3.40785760799 | 138.21 | 156.61 | 129.2 | 2125957 | 142.48992005 | CS |
26 | 24.26 | 22.207982424 | 109.24 | 156.61 | 103.52 | 1917101 | 132.29994139 | CS |
52 | -7.19 | -5.11052668989 | 140.69 | 156.61 | 100.085 | 2022062 | 127.71052972 | CS |
156 | -248.55 | -65.0569297212 | 382.05 | 427.9999 | 89 | 1683035 | 170.20677131 | CS |
260 | -202.01 | -60.2098298113 | 335.51 | 555.77 | 89 | 1436598 | 226.91480194 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions